KMKateryna Misiura

Kateryna Misiura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kateryna Misiura has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The potential role of the SLC22A1 rs628031 A>G polymorphism in the pathogenetic mechanisms of hormonal and metabolic response to antihyperglycemic therapy

    by T.V. Tyzhnenko, K.V. Misiura, A.O. Kolesnikova, O.O. Plohotnichenko, A.K. Pocherniaiev, I.O. Marakhovskyi, M.YU. Gorshunska, Zh.A. Leshchenko, I.A. Tykha, Karolina Biernot Pamuła, et al.

    Background. Metformin is widely used as a first-line antihyperglycemic therapy in patients with type 2 diabetes mellitus (T2DM); however, individual variability in treatment response remains an important clinical issue. Genetic variations in the solute carrier family 22 member 1 (SLC22A1) gene, encoding the organic cation transpor­ter 1 (OCT1), may influence metformin pharmacokinetics and metabolic effects. The purpose of this study was to eva­luate the potential role of the SLC22A1 rs628031 A>G (Met408Val) polymorphism in the pathogenetic mechanisms of hormonal and metabolic responses to antihyperglycemic therapy in patients with T2DM and obesity. Materials and methods. The study included 61 patients with T2DM aged 28–80 years (35 men and 26 women) with metabolic syndrome and obesity (body mass index ≥ 30 kg/m2). All patients received oral antihyperglycemic therapy, including metformin, sulfonylureas, or their combinations. According to the antihyperglycemic therapy received, the patients were retrospectively divided into two groups: those receiving metformin-based therapy and those treated with other glucose-lowering agents (sulfonylureas or their combinations without metformin). Clinical, anthropometric, biochemi­cal, hormonal, and metabolic parameters were assessed, including carbohydrate and lipid metabolism indices, liver function markers, adipokine profile, and oxidative stress parameters. Genotyping of the SLC22A1 rs628031 A>G polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism analysis with MscI restriction enzyme. Results. Metformin-based therapy was associated with favorable changes in glycemic control, lipid profile, adipokine status, and oxidative stress markers in patients with T2DM and obesity. Carriers of the AG genotype of the SLC22A1 rs628031 polymorphism receiving metformin demonstrated significantly lower levels of low-density lipoprotein cholesterol, total cholesterol, omentin, osteoprotegerin, alanine aminotransferase, and aspartate aminotransferase compared with other genotype groups. At the same time, AG genotype carriers showed higher omentin and osteoprotegerin concentrations compared with AA genotype carriers, suggesting genotype-dependent modulation of metformin-associated metabolic effects. Conclusions. The obtained results indicate that the SLC22A1 rs628031 A>G polymorphism may contribute to variability in hormonal and metabolic responses to metformin therapy in patients with T2DM and obesity. Genetic differences in OCT1 function may influence lipid metabolism, adipokine regulation, liver homeostasis, and potentially bone-related metabolic processes. Assessment of SLC22A1 genetic variants may contribute to the development of personalized approaches for optimizing antihyperglycemic therapy and improving metabolic outcomes in patients with diabetes and metabolic disorders.

  • Open Access

    Plasma atherogenic index as a non-invasive criterion for the diagnosis of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

    by O.O. Plokhotnichenko, T.V. Tyzhnenko, K.V. Misiura, I.A. Tykha, N.O. Kravchun, I.A. Lurin, M.YU. Gorshunska, A.K. Pocherniaiev, V.V. Kurinnyi, Zh.A. Leshchenko, et al.

    Background. Identification of risk factors and detection of target organs in the early stages of the formation of cardiovascular diseases, liver and kidney diseases and other complications with the correction of identified disorders is an integral part of the successful reduction of morbidity and mortality among the population. Diabetes mellitus (DM) is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. The purpose of the study was to determine the presence and nature of the relationship of a new indirect index with the presence (or absence) of metabolically associated steatotic fatty liver disease (MASLD) in patients with T2DM, to determine the contribution of the atherogenic index of plasma (AIP) to the risk of developing liver disease and to characterize its diagnostic value using logistic regression and ROC analysis. Materials and methods. Sixty patients with T2DM were examined (33/27 men/women; age 53.00 ± 1.20 years; disease duration 13.36 ± 3.49 years), of them 24 participants with MASLD and 36 without it. The diagnosis of MASLD was established on the basis of clinical analysis of the disease, lipid and carbohydrate metabolism indicators, aspartate aminotransferase and alanine aminotransferase activity and ultrasound examination of the liver. Results. A significant and statistically significant relationship was found between the AIP and the presence of metabolically associated fatty liver disease. A distinct and significant correlation was established between the AIP and glycemia, as well as some indicators of oxidative stress (in particular, the index of free fatty acids and OXY levels) and the level of lipocalin, an adipokine. A diagnostic model was developed to identify risk groups for the development of MASLD in patients with T2DM based on the AIP. Conclusions. A diagnostic model was developed to form risk groups for MASLD among patients with T2DM using logistic regression and ROC analysis. The diagnostic criterion is a new non-invasive indicator — the AIP, the threshold value of the predictor is defined as 0.60.

  • Open Access

    On the use of portable X-ray equipment in the diagnosis and clinical monitoring of diabetes

    by I.F. Mikhailov, A.I. Mikhailov, N.YU. Seliukova, V.V. Nehoduiko, K.V. Misiura

    Background. Type 2 diabetes mellitus is one of the leading global medical and social problems, the prevalence of which is constantly increasing. Violation of microelement homeostasis plays an important role in the pathogenesis of the disease, affecting the deve­lopment of insulin resistance, oxidative stress and vascular complications. In this regard, the search for accessible and accurate methods for quantitative determination of microelements in biological tissues is of particular importance. The purpose of the study was to conduct a comprehensive analysis on the role of essential microelements in the pathogenesis of diabetes mellitus and to substantiate the feasibility of using portable X-ray equipment for their quantitative moni­toring in situ. Materials and methods. A review of scientific sources published in 2000–2025 was conducted using the PubMed, Scopus, Web of Science and Google Scholar databases. Data on the role of calcium, magnesium, iron, chromium, zinc, boron, cobalt, iodine and selenium in the development of diabetes mellitus were analyzed. For the quantitative determination of trace elements in blood plasma, the use of a portable energy-dispersive X-ray fluorescence spectro­meter SPRUT with an Amptek SDD detector was proposed. Sample preparation included drying of blood plasma, ashing and pressing of the dry residue. Calibration was performed by the standard addition method using standard samples RM 23, RM 24, RM 26 and RM 30. Results. It was found that magnesium, zinc, chromium, calcium and selenium deficiency is associated with decreased insulin sensitivity, impaired insulin secretion, oxidative stress and progression of vascular complications. Iron overload, on the contrary, contributes to the enhancement of pro-oxidant processes and the development of insulin resistance. It is shown that the trace element profile can be used as an early biomarker of metabolic disorders even before the clinical manifestation of diabetes. The proposed X-ray fluorescence technique provides a limit of detection of trace elements at the level of 10–50 ng, which corresponds to modern highly sensitive analysis methods. The use of portable equipment allows for research to be conducted directly in the clinic without complex sample preparation and expensive stationary equipment. Conclusions. Violation of the trace element status is an important factor in the development and progression of diabetes mellitus. Portable X-ray fluorescence equipment is a promising tool for the express determination of trace elements in biological tissues, which opens up opportunities for early diagnosis, prediction of complications and personalized monitoring of patients with diabetes mellitus.

  • Open Access

    Features of diagnosis and treatment of neck gunshot injuries with thyroid damage

    by E. M. Khoroshun, V. V. Makarov, S. I. Panasenko, V. V. Nehoduiko, B. M. Chernobil, K. V. Misiura, N. Y. Seliukova

    Objective — to analyze the results of diagnosis and treatment of gunshot wounds of the neck with thyroid gland injury in order to determine the optimal diagnostic and treatment strategy. Materials and methods. The study included 68 men (mean age — 34.2±3.1 years), divided into two groups: the main group (33 patients, 2022 — 2026), in which the authors’ methods were implemented, and the comparison group (35 patients, 2014 — 2022), treated using the traditional approach. The diagnostic complex included clinical and instrumental methods, in particular radiological examinations, endoscopy, metal detection and laser imaging. Computer vision algorithms were used to accurately determine the size of foreign bodies, and morphological changes in tissues were assessed histologically. Treatment outcomes were evaluated in the early, intermediate (up to 1 year), and long-term (more than 1 year) follow-up periods using questionnaires and methods of mathematical statistics. Results. Combat neck trauma accounted for 4.5% of all hospitalized patients, with combined injuries (69.8%) and shrapnel injuries (87.2%) dominating. The structure of injuries was dominated by soft tissue injuries (83.3%), and injuries to the neck organs (pharynx, trachea, vessels, thyroid gland, etc.) were recorded in 16.7% of cases, of which 12.6% were injuries to two or more organs. Comprehensive diagnostics was based on ultrasound examination, multislice computed tomography (MSCT) with contrast enhancement, and endoscopic methods. Primary surgical wound debridement was performed in 41.4% of cases, whereas conservative treatment was used in 34.3%. For thyroid gland injuries, bilateral colotomy (57.4%) was most commonly performed; among surgical interventions, primary surgical wound debridement (44.1%) and thyroid resection predominated. The introduction of advanced diagnostic and treatment methods in the main group allowed to double the efficiency of foreign body removal, reduce the operation time by three times, and the duration of hospitalization by 7 days. There was also a 2.4-fold decrease in the frequency of complications (from 25% to 10.3%) and a decrease in the number of cases of postoperative hypothyroidism. Long-term results in the main group were significantly better due to the predominance of good results (43.3% versus 31.7%) and the absence of unsatisfactory consequences. Conclusions. Comprehensive verification of gunshot injuries to the thyroid gland, with emphasis on radiological diagnostics, ensures accurate injury stratification and optimal selection of surgical management. Implementation of the authors’ clinical and tactical classification simplifies decision-making by replacing the empirical approach with a standardized one. This made it possible to significantly (p<0.05) double the completeness of foreign body removal, reduce extraction time threefold, and shorten hospitalization by 7 days. Comparative analysis confirmed the superiority of the improved methodology: the proportion of good outcomes increased to 43.3% (versus 31.7% in the comparison group), with no unsatisfactory outcomes recorded.

  • Open Access

    EFFECT OF SIRT1 GENE POLYMORPHISM (rs2273773) ON CARDIOVASCULAR RISK MARKERS IN OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES MELLITUS OF THE EAST UKRAINIAN POPULATION

    by Nataliya Krasova, Alla Kolesnikova, Maryana Gorshunska, Plohotnichenko O. O., Tetiana Tyzhnenko, Zhanna Leshchenko, Dmytro Shapoval, Tetiana Voropay, Iryna Romanova, Kateryna Misiura

    There is evidence that sirtuins as energy sensors contribute to the pathogenesis of obesity and related metabolic and cardiovascular diseases in humans. The single nucleotide polymorphism (SNP) C > T (rs2273773) of the SIRT1 gene is a so-called «silent» mutation in exon 5 and may be linked to other mutations that affect both sirtuin-1 protein levels and its activity. The aim of the study was to assess the association of polymorphic variants rs2273773 of the sirtuin-1 gene with characteristics of insulin resistance and hormonal activity of adipose tissue in overweight patients with type 2 diabetes from the East Ukrainian population. Materials and methods. The study was conducted in accordance with international and domestic ethical and legal requirements and was approved by the Medical Ethics Committee at the IEPP. All examined patients underwent inpatient treatment at the institute's clinic. A retrospective analysis of clinical and biochemical parameters obtained for patients whose samples are included in the DNA collection of patients with type 2 diabetes mellitus (DM) was conducted. 61 patients with type 2 DM (male/female: 27/34) aged 53.35 ± 1.38 years, with diabetes duration of 5.33 ± 0.67 years, glycosylated hemoglobin level of 7.74 ± 0.19%, with body mass index of 33.28 ± 0.89 kg/m2, and with waist-to-hip ratio of 0.99 ± 0.01 were selected. Antidiabetic therapy included sulfonamides, biguanides, or their combinations. Clinical, biochemical, and enzyme-linked immunosorbent assay measurements were performed at the National Institute for Public Health and the Environment (Bilthoven, the Netherlands) within the framework of scientific cooperation. Insulin resistance was characterized by the HOMA-IR index, HOMA-IR/adiponectin, adiponectin/leptin, HOMA-IR/leptin, Adipo-IR and a number of other surrogate indices. The pathological impact of dyslipidemia was assessed by Castelli risk indices I and II and triglyceride-glucose index. Determination of the single-nucleotide substitution of cytosine for thymine in exon 5 of the SIRT1 gene rs2273773 (C > T) was carried out by polymerase chain reaction with two pairs of opposite primers. Electrophoretic fractionation determined the following genotypes for the rs2273773 (C > T) SIRT1 gene: CC — 314/228 bp; CT — 314/228/135 bp; TT — 314/135 bp. Allele frequencies for the studied genotype were calculated. The normality of the distribution of variables was determined using the Kolmogorov-Smirnov criterion. To compare the indicators characterized by normal distribution, the unpaired two-tailed Student's t-test was used, to compare the parameters with non-normal distribution, the Mann-Whitney test. To statistically assess the differences observed between the empirical and theoretical frequencies of the variation series, the χ2 (chi-square) test was used. Results. Genotyping according to the above-mentioned SNP indicates that there is no accumulation of certain genotypes under the conditions of the studied pathology. A preliminary analysis of the polymorphism functional significance was performed using a recessive inheritance model, i.e. CC-carriers (n = 24) versus CT + TT (n = 37). Analysis of clinical parameters revealed that this SNP did not have a statistically significant effect on the age of manifestation of type 2 DM, the degree of diabetes compensation, HOMA-IR, atherogenicity indices, blood pressure, and degree of obesity. However, there was a trend (0.05 < P < 0.1) towards worse indicators characterizing insulin resistance of adipose tissue (HOMA-IR/adiponectin, HOMA-IR/leptin, adiponectin/leptin) in carriers of the mutant T-allele. The above was accompanied by a shift in the triglyceride-glucose index (CC-carriers: 8.15 (4.29; 14.81) units vs 10.91 (6.88; 16.39) units in the CC + CT group, 0.05 < P < 0.1) and dyslipidemia parameters (triglycerides, high-density lipoprotein cholesterol). The mutant T-allele has been found to have a negative effect on indicators related to the hormonal function of adipose tissue. Thus, there is a statistically significant decrease in the levels of the most active form of anti-inflammatory adipocytokine — high molecular weight adiponectin — in T-allele carriers relative to the indicator for the CC genotype (1.96 ± 0.19 vs 3.09 ± 0.50 mg/L, respectively, P < 0.05). This was accompanied by a decrease in the levels of vaspin, an adipokine that increases insulin sensitivity, inhibits the synthesis of pro-inflammatory cytokines, and is involved in the regulation of food intake (CC-carriers: 0.33 (0.20; 0.64) vs 0.19 (0.08; 0.49) μg/L in the CC + CT group, P < 0.05). There are trends toward higher levels of chronic inflammation markers (TNF-α, IL-6, and IL-1b), which, however, do not reach statistical significance. In addition, carriers of the T-allele had significantly higher superoxide dismutase activity (24.77 ± 0.92 vs 20.46 ± 0.68 kU/mmol Hb in CC-carriers, P < 0.01) and levels of total (44.24 ± 3.45 vs 31.39 ± 2.96 μmol/mmol Hb in CC-carriers, P < 0.01) and reduced glutathione (35.10 ± 2.96 vs 21.86 ± 2.24 μmol/mmol Hb in CC-carriers, P < 0.01) in erythrocytes. The above is most likely compensatory in nature and indicates active lipoperoxidation processes. Conclusions. Analysis of the hormonal activity of adipose tissue suggests a higher cardiovascular risk in carriers of the minor allele of the C > T rs2273773 polymorphism of the sirtuin-1 gene among overweight patients with type 2 diabetes in the East Ukrainian population. The results obtained can be used to optimize prevention and treatment regimens for overweight individuals and patients with type 2 diabetes, which will help maintain working capacity and increase the duration and quality of life.

  • Open Access

    Adiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 as one of the factors in the pharmacogenetics of type 2 diabetes mellitus

    by O.O. Plohotnichenko, T.V. Tyzhnenko, K.V. Misiura, I.A. Tykha, M.YU. Gorshunska, A.K. Pochernyaev, Karolina Biernot Pamuła, N.S. Krasova, Zh.A. Leshchenko, A.O. Kolesnikova, et al.

    Background. Diabetes mellitus is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. Numerous risk factors for the development of type 2 diabetes have been identified, the most important of which is the pathogenetic contribution of visceral obesity. Adipose tissue is now understood to be an active endocrine organ, secreting various hormones and cytokines that regulate metabolism and inflammation. The ADIPOQ gene located on chromosome 3q27, a region that recent scans of the entire human genome have suggested as a “type 2 diabetes susceptibility locus”, encodes the hormone adiponectin, which is derived from adipose tissue. The purpose of the study is to clarify the role of the adiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 in the mechanisms of pharmacogenetic response in patients with obesity and type 2 diabetes, taking into account the assessment of its impact on the course and effectiveness of therapy. Materials and methods. Sixty-one people were selected for analysis. All patients received oral hypoglycemic drugs: sulfonamides, biguanides or their combination before hospitalization in the clinic. A comparative analysis of a number of biochemical parameters was conducted in the groups that took or did not take metformin as the main sugar-­lowering drug, considering the single nucleotide polymorphism of the adiponectin gene. Results. The results indicate that the aforementioned drug has antioxidant properties, a certain hepatoprotective effect (a significant decrease in aspartate and alanine aminotransferase in G allele carriers who received the drug); also, the ability to improve the lipid profile, including in G allele carriers, has been statistically proven, that is, it has the potential to reduce the risk of developing cardiovascular complications, which is the main cause of death in patients. Conclusions. Genetic testing can be used to divide patients with type 2 diabetes and obesity into specific clusters and/or endophenotypes. Advances in the field of pharmacogenomics will allow clinicians to select personalized drug therapy regimens in order to increase its effectiveness and reduce the risk of developing adverse events.

  • Open Access

    Evaluation of the efficacy of metformin in prediabetes taking into account the metabolic characteristics of perimenopausal women: a literature review

    by N.YU. Seliukova, I.A. Lurin, T.V. Tyzhnenko, K.V. Misiura

    This review aims to examine the efficacy of metformin in the prevention of type 2 diabetes mellitus (T2DM) in perimenopausal women with prediabetes. The authors emphasize that prediabetes is a serious condition that affects millions of people worldwide, with a high risk of progression to T2DM, especially in women. Therefore, early intervention is critical. The literature search metho­dology included a systematic review of scientific databases such as PubMed, Scopus, and Web of Science, using appropriate keywords to identify relevant publications. The article emphasizes that there are significant gaps in the study of the impact of prediabetes оn women during the perimenopausal period, which is characterized by pronounced hormonal fluctuations. Such insufficient research is problematic, since hormonal changes can significantly affect metabolism and the effectiveness of therapy. Metformin, despite its recognized role in the treatment of T2DM, exhibits multifaceted effects that go beyond simple glycemic control. The review systemati­zes data on its effects on weight loss and inflammation (metformin promotes the reduction of visceral fat, improves sensitivity to satiety hormones, and has anti-inflammatory effects); effects on endocrine axes (the drug modulates the hypothalamic-pituitary-ovarian and hypothalamic-pituitary-thyroid axes, and also reduces prolactin levels, these effects depend on dosage and estradiol levels); gynecological diseases (it is effectively used in polycystic ovary syndrome and the treatment of proliferative endometrial changes); and pharmacological profile (the authors review the mechanisms of action of metformin, including its effects on AMPK activation and interaction with the intestinal microbiota). The review highlights that, despite the established efficacy of metformin in the prevention of T2DM, data on its use in perimenopausal women are limited. This is due to the lack of targeted studies, as well as the need to take into account individual hormonal fluctuations. Thus, the authors emphasize the need for well-designed randomized controlled trials that would allow the development of personalized and effective therapeutic strategies for women with prediabetes during this period of life.

  • Open Access

    ЗВ'ЯЗОК МІЖ ПОРАНЕННЯМИ ВІЙСЬКОВОСЛУЖБОВЦІВ ТА РОЗВИТКОМ ЦУКРОВОГО ДІАБЕТУ (ОГЛЯД ЛІТЕРАТУРИ)

    by Ігор Лурін, Катерина Місюра, Наталія Селюкова, Тетяна Тижненко, Едуард Хорошун, Віталій Макаров, Володимир Негодуйко, Igor Lurin, Kateryna Misiura, Nataliia Seliukova, et al.

    The article examines and systematizes the existing knowledge on the potential link between combat-related injuries in service members and the subsequent development of diabetes mellitus (DM). The aim of the study is to comprehensively analyze the possible physiological and psychological mechanisms underlying this association, as well as to review the available statistical data and scientific research in this field. A literature search was conducted using the databases Web of Science, Scopus, MedLine, etc. The results of the analysis indicate that certain types of injuries, in particular those accompanied by significant physical and psychological stress, traumatic brain injuries, amputations, or chronic inflammatory processes, may create a favorable environment for increasing the risk of developing DM in service members. These conditions are capable of inducing complex neuroendocrine and metabolic changes that disrupt the regulation of blood glucose levels and lead to insulin resistance. The authors emphasize the critical importance of timely identification of risk factors for DM in service members who have survived injuries. Regular medical examinations, including assessment of metabolic status and the presence of comorbidities, are necessary for early diagnosis and implementation of preventive measures. In addition, the promotion of a healthy lifestyle, including a balanced diet and sufficient physical activity, can play a significant role in reducing the likelihood of developing diabetes in this vulnerable population. Thus, the article emphasizes the need for further research to better understand the pathogenetic mechanisms linking injuries and diabetes in military personnel, as well as to develop effective strategies for medical support and prevention of this disease among veterans. The knowledge gained will contribute to the optimization of medical care and improvement of the quality of life of military personnel after returning from the combat zone.


  • Open Access

    Classification of gunshot wounds of the thyroid gland

    by E.M. Khoroshun, I.A. Lurin, K.V. Misiura, V.V. Makarov, V.V. Nehoduiko, Yu.V. Bunin, B.M. Chernobil, N.YU. Seliukova

    Background. The article analyzes the examination and treatment of gunshot wounds of the neck with damage to the thyroid gland (TG) over the past 3 years in the conditions of the Military Medical Clinical Center of the Northern Region of the Medical Forces Command. The aim is to develop and implement a classification of gunshot wounds of the neck with damage to the TG. Materials and methods. All patients were male, had gunshot shrapnel wounds of the neck. Laboratory tests were performed, as well as ultrasound examination of the neck, multispiral computed tomography of the head, neck, chest and abdominal organs, pelvis with and without contrast, X-ray examinations of the chest and abdominal organs, video esophagogastroduodenoscopy and vi­deo bronchoscopy, electrocardiography. Results. The frequency of gunshot wounds to the neck with damage to the TG by years (2022, 2023, 2024) is 5.2, 9.3, 8.7 %. It has increased over the past 2 years, which is associated with the use of drones by the enemy. On average, according to our data, thyroid injuries among gunshot wounds to the neck with damage to hollow and parenchymal organs account for 7.5 %. The classification is based on the extent of the injury, appropriate treatment, and possible hormone replacement therapy (when it was not prescribed before the injury), which are distributed by class. The distribution by the extent of damage is as follows: сlass I — contusion of the TG, сlass II — superficial damage (up to 0.5 cm deep), сlass III — deep damage, up to 50 % of the lobe, сlass IV — deep damage, more than 50 % of the lobe, сlass V — crushing of the TG. The frequency of thyroid injuries is distributed by class: class II — 41.4 %, class I — 34.3 %, class III — wedge or marginal resection, pole or isthmus resection: 20.7 %, class IV — hemithyroidectomy: 3.4 %, class V — thyroidectomy: 0 %. All injuries were shrapnel. Isolated injuries of the TG were not identified, which is associated with its anatomical location. According to treatment, class II — primary surgical wound treatment: 41.4 %, class I — conservative therapy: 34.3 %, class III — 20.7 %, class IV — 3.4 %, class V — 0 %. Hormone replacement therapy was subsequently prescribed to patients with class IV. The average duration of treatment was 10.2 ± 1.3 days. Conclusions. Gunshot wounds of the neck with damage to the TG are a rare pathology. The proposed classification allows us to determine the treatment and prognosis. The anatomical and physiological features of the TG should be taken into account during surgical treatment for thyroid injury. Surgical interventions for thyroid injuries should be performed at the Role IV with the availability of appropriate specialists and equipment.


  • Open Access

    Continuous glucose monitoring using wearable devices: technological achievements and world trends

    by N.YU. Seliukova, I.A. Lurin, K.S. Smelyakov, A.S. Chupryna, T.V. Tyzhnenko, K.V. Misiura

    Diabetes is a long-term disease characterized by elevated blood glucose levels, potentially damaging multiple organs and systems. Monitoring glucose levels, whether continuous or intermittent, is essential not only for people with diabetes but also for the general population. Although the past decade has brought significant advances in glucose monitoring technologies through the work of researchers and manufacturers, the field of glucose biosensors still faces significant challenges. A thorough literature search was conducted in the scientific databases Scopus, Science Direct (by Elsevier), and PubMed, including MEDLINE, to prepare this work. The following keywords were used for the search: “glucose monitoring”, “continuous glucose monitoring”, “wearable devices”, “glucose biosensors”, “diabetes”, “artificial intelligence in diabetes”, and “personalized medicine”. In this article, the authors review in detail the latest developments in glucose monitoring, including invasive, minimally invasive, and noninvasive approaches. The integration of electronic components, wireless communication technologies, energy harvesting systems were analyzed, and limitations of current solutions were assessed. Additionally, the potential of combining medical data from continuous glucose monitors with artificial intelligence techniques is highlighted to develop accurate diabetes treatment protocols. This approach provides high accuracy of results with short-term prediction based on time series of glucose readings. The authors highlight the urgent need for further improvement of glucose monitoring technologies, which is crucial for optimizing diabetes therapy and meeting important clinical demands for advanced monitoring solutions with practical applications.